{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:41:00Z","timestamp":1774611660735,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,14]]},"DOI":"10.7759\/cureus.56179","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T19:28:57Z","timestamp":1710444537000},"source":"Crossref","is-referenced-by-count":1,"title":["Dermatologists\u2019 and Rheumatologists\u2019 Adherence to the Latest Recommendations for Screening of Hydroxychloroquine Retinopathy in Saudi Arabia: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Asail S","family":"Alghamdi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghaida B","family":"AlQefari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalil","family":"Alduraibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Al-Amer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basil A","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed N","family":"Alqefari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana N","family":"Alqifari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meshal M","family":"Alhameedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317700486","article-title":"Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases","volume":"26","author":"Bahloul E","year":"2017","unstructured":"Bahloul E, Jallouli M, Garbaa S, Marzouk S, Masmoudi A, Turki H, Bahloul Z. Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases. Lupus. 2017, 26:1304-8. 10.1177\/0961203317700486","journal-title":"Lupus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23826","article-title":"Clinical and structural efficacy of hydroxychloroquine in rheumatoid arthritis: a systematic review","volume":"72","author":"Rempenault C","year":"2020","unstructured":"Rempenault C, Combe B, Barnetche T, Gaujoux-Viala C, Lukas C, Morel J, Hua C. Clinical and structural efficacy of hydroxychloroquine in rheumatoid arthritis: a systematic review. Arthritis Care Res (Hoboken). 2020, 72:36-40. 10.1002\/acr.23826","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.068676","article-title":"Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)","volume":"66","author":"Alarc\u00f3n GS","year":"2007","unstructured":"Alarc\u00f3n GS, McGwin G, Bertoli AM, et al.. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis. 2007, 66:1168-72. 10.1136\/ard.2006.068676","journal-title":"Ann Rheum Dis"},{"key":"ref4","unstructured":"American Academy of Ophthalmology. Hydroxychloroquine-induced retinal toxicity. (2011). https.\/\/www.aao.org\/eyenet\/article\/hydroxychloroquine-induced-retinal-toxicity."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2018.01.019","article-title":"Pericentral hydroxychloroquine retinopathy in a Caucasian female","volume":"9","author":"Anand N","year":"2018","unstructured":"Anand N, Prinzi RA, Hoeferlin C, Yan J, Jain N. Pericentral hydroxychloroquine retinopathy in a Caucasian female. Am J Ophthalmol Case Rep. 2018, 9:93-5. 10.1016\/j.ajoc.2018.01.019","journal-title":"Am J Ophthalmol Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7326\/M22-2453","article-title":"Hydroxychloroquine dose and risk for incident retinopathy: a cohort study","volume":"176","author":"Melles RB","year":"2023","unstructured":"Melles RB, Jorge AM, Marmor MF, et al.. Hydroxychloroquine dose and risk for incident retinopathy: a cohort study. Ann Intern Med. 2023, 176:166-73. 10.7326\/M22-2453","journal-title":"Ann Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-022-02159-3","article-title":"Outcomes of screening for hydroxychloroquine retinopathy at the Manchester Royal Eye Hospital: 2 years' audit","volume":"37","author":"Alieldin RA","year":"2023","unstructured":"Alieldin RA, Boonarpha N, Saedon H. Outcomes of screening for hydroxychloroquine retinopathy at the Manchester Royal Eye Hospital: 2 years' audit. Eye (Lond). 2023, 37:1410-5. 10.1038\/s41433-022-02159-3","journal-title":"Eye (Lond)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-018-0111-8","article-title":"Hydroxychloroquine retinopathy - implications of research advances for rheumatology care","volume":"14","author":"Jorge A","year":"2018","unstructured":"Jorge A, Ung C, Young LH, Melles RB, Choi HK. Hydroxychloroquine retinopathy - implications of research advances for rheumatology care. Nat Rev Rheumatol. 2018, 14:693-703. 10.1038\/s41584-018-0111-8","journal-title":"Nat Rev Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.01.058","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision)","volume":"123","author":"Marmor MF","year":"2016","unstructured":"Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology. 2016, 123:1386-94. 10.1016\/j.ophtha.2016.01.058","journal-title":"Ophthalmology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2196\/15218","article-title":"Dermatologists\u2019 adherence to the latest recommendations for screening of hydroxychloroquine retinopathy in Saudi Arabia: cross-sectional study","volume":"8","author":"Mleeh NT","year":"2019","unstructured":"Mleeh NT, Alzahrani NA, Hariri JO, Mortada HH, Algethami MR. Dermatologists\u2019 adherence to the latest recommendations for screening of hydroxychloroquine retinopathy in Saudi Arabia: cross-sectional study. Interact J Med Res. 2019, 8:e15218. 10.2196\/15218","journal-title":"Interact J Med Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2021.07.005","article-title":"Hydroxychloroquine: an essential drug in dermatology and its controversial use in COVID-19. (Article in Spanish)","volume":"113","author":"Morgado-Carrasco D","year":"2022","unstructured":"Morgado-Carrasco D, Ibaceta-Ayala J, Piquero-Casals J. Hydroxychloroquine: an essential drug in dermatology and its controversial use in COVID-19. (Article in Spanish). Actas Dermosifiliogr. 2022, 113:166-75. 10.1016\/j.ad.2021.07.005","journal-title":"Actas Dermosifiliogr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2020-000427","article-title":"Rheumatologists' perspective on hydroxychloroquine guidelines","volume":"7","author":"Winebrake J","year":"2020","unstructured":"Winebrake J, Khalili L, Weiner J, Gartshteyn Y, Park L, Askanase AD. Rheumatologists' perspective on hydroxychloroquine guidelines. Lupus Sci Med. 2020, 7:e000427. 10.1136\/lupus-2020-000427","journal-title":"Lupus Sci Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/art.41683","article-title":"American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 joint statement on hydroxychloroquine use with respect to retinal toxicity","volume":"73","author":"Rosenbaum JT","year":"2021","unstructured":"Rosenbaum JT, Costenbader KH, Desmarais J, et al.. American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 joint statement on hydroxychloroquine use with respect to retinal toxicity. Arthritis Rheumatol. 2021, 73:908-11. 10.1002\/art.41683","journal-title":"Arthritis Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.01.012","article-title":"Updated recommendations on the use of hydroxychloroquine in dermatologic practice","volume":"76","author":"Fernandez AP","year":"2017","unstructured":"Fernandez AP. Updated recommendations on the use of hydroxychloroquine in dermatologic practice. J Am Acad Dermatol. 2017, 76:1176-82. 10.1016\/j.jaad.2017.01.012","journal-title":"J Am Acad Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20073","article-title":"New recommendations for retinal monitoring in hydroxychloroquine users: baseline testing is no longer supported","volume":"185","author":"Yusuf IH","year":"2021","unstructured":"Yusuf IH, Latheef F, Ardern-Jones M, Lotery AJ. New recommendations for retinal monitoring in hydroxychloroquine users: baseline testing is no longer supported. Br J Dermatol. 2021, 185:435-8. 10.1111\/bjd.20073","journal-title":"Br J Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2014.1099","article-title":"Effect of disease stage on progression of hydroxychloroquine retinopathy","volume":"132","author":"Marmor MF","year":"2014","unstructured":"Marmor MF, Hu J. Effect of disease stage on progression of hydroxychloroquine retinopathy. JAMA Ophthalmol. 2014, 132:1105-12. 10.1001\/jamaophthalmol.2014.1099","journal-title":"JAMA Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316660204","article-title":"Implementation of recommendations for the screening of hydroxychloroquine retinopathy: poor adherence of rheumatologists and ophthalmologists","volume":"26","author":"Shulman S","year":"2017","unstructured":"Shulman S, Wollman J, Brikman S, Padova H, Elkayam O, Paran D. Implementation of recommendations for the screening of hydroxychloroquine retinopathy: poor adherence of rheumatologists and ophthalmologists. Lupus. 2017, 26:277-81. 10.1177\/0961203316660204","journal-title":"Lupus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/171887-dermatologists-and-rheumatologists-adherence-to-the-latest-recommendations-for-screening-of-hydroxychloroquine-retinopathy-in-saudi-arabia-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T19:29:01Z","timestamp":1710444541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/171887-dermatologists-and-rheumatologists-adherence-to-the-latest-recommendations-for-screening-of-hydroxychloroquine-retinopathy-in-saudi-arabia-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.56179","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,14]]}}}